[CALT] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[CALT] Calliditas Therapeutics AB (publ)
Announcement Date
29-Sep-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -83.13%
YoY- -1,748.05%
Quarter Report
CALT's Result
CALT's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 559,780 295,481 451,561 294,592 269,384 191,352 429,042 19.42%
PBT -42,661 -247,324 -14,256 -164,082 -70,660 -208,019 10,066 -
Tax 4,817 -1,164 4,112 4,276 21,274 -20,494 13,747 -50.32%
NP -47,478 -246,160 -18,368 -168,357 -91,934 -187,525 -3,681 450.84%
Tax Rate - - - - - - -136.57% -
Total Cost 607,258 541,641 469,929 462,949 361,318 378,877 432,723 25.37%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -8.48 -83.31 -4.07 -57.15 -34.13 -98.00 -0.86 360.47%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.88 -9.17 -0.34 -3.14 -1.71 -3.49 -0.07 441.49%
EPS Diluted -0.88 -9.17 -0.34 -3.14 -1.71 -3.49 -0.07 441.49%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.